Skip to content

The effect of oral vitamin D on the sleep quality in postmenopausal women

Comparison of the effectiveness of oral vitamin D and placebo on sleep quality in menopausal women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250126064515N1
Enrollment
52
Registered
2025-02-26
Start date
2025-02-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep quality.

Interventions

Intervention 1: Intervention group: Taking a 1000 IU vitamin D supplement twice daily for up to 8 weeks. Intervention 2: Control group: They will take two placebo pills daily for up to 8 weeks, which

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: At least one year since last menstrual period Poor sleep quality (score of 5 or more on the Petersburg Questionnaire) Age range 45-65 years Vitamin D level less than 20 units

Exclusion criteria

Exclusion criteria: The presence of any physical or mental illness that causes sleep disorders (such as shortness of breath, thyroid disorders, depression, etc.) Using hormonal medications Using medications that affect sleep Using tobacco and alcohol A significant change in sleep conditions that is unpredictable (such as traveling, changing locations, severe stress, etc.) Sensitivity to vitamin D supplements, other vitamins, drug allergies The presence of a spouse's illness that affects mental health and sleep. Liver diseases Metabolic diseases, diabetes, and chronic kidney diseases

Design outcomes

Primary

MeasureTime frame
Percentage of people whose Petersburg questionnaire score is above 5. Timepoint: Completion of the Petersburg Sleep Quality Questionnaire before the intervention and 60 days after starting vitamin D supplementation. Method of measurement: Petersburg Sleep Quality Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ghazanfari

Ahvaz University of Medical Sciences

ghazanfarizahra04@gmail.com+98 61 3373 8538

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026